Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,370,621 papers from all fields of science
Search
Sign In
Create Free Account
CTNNA2 gene
Known as:
CAPR
, CTNNA2
, CT114
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
CTNNA3 gene
Ctnna2 protein, mouse
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Novel-miR-4885 Promotes Migration and Invasion of Esophageal Cancer Cells Through Targeting CTNNA2.
Jing Song
,
Peng Zhang
,
+6 authors
Ran Liu
DNA and Cell Biology
2019
Corpus ID: 54479819
Esophageal cancer is one of the most common cancers worldwide. It is critical to find early diagnostic biomarkers for esophageal…
Expand
2019
2019
Abstract CT114: INO-5401 and INO-9012 delivered by electroporation (EP) in combination with cemiplimab (REGN2810) in newly-diagnosed glioblastoma (GBM) (NCT03491683)
D. Reardon
,
S. Nagpal
,
+12 authors
J. Skolnik
Clinical Trials
2019
Corpus ID: 198307157
Despite advances in therapy, glioblastoma (GBM) remains one of the most deadly cancers, with five-year survival under 5%. Newer…
Expand
2018
2018
Abstract CT114: Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced non-small cell lung cancer (NSCLC): results of the phase 3 CheckMate 078…
Yi-long Wu
,
Shun Lu
,
+17 authors
Jian-hua Chang
Clinical Trials
2018
Corpus ID: 80657425
Introduction: Lung cancer incidence in China has increased and it remains the leading cause of cancer death, highlighting a need…
Expand
2015
2015
Abstract CT114: A phase II trial of exemestane and ruxolitinib for aI-resistant ER+ breast cancer: Interim safety, efficacy, and biomarker analysis
A. DeMichele
,
Christopher Colameco
,
+14 authors
J. Bromberg
2015
Corpus ID: 59188468
Resistance to aromatase inhibitors in ER+ breast cancer leads to recurrence and progression in the metastatic setting. JAK/STAT…
Expand
2013
2013
SUBSTRATE-DEPENDENT EXPRESSION OF LACCASE IN GENETICALLY MODIFIED Escherichia coli: DESIGN AND CONSTRUCTION OF AN INDUCIBLE PHENOL-DEGRADING SYSTEM
Mehrnoosh Fathi-Roudsari
,
M. Behmanesh
,
A. Salmanian
,
M. Sadeghizadeh
,
K. Khajeh
Preparative Biochemistry & Biotechnology
2013
Corpus ID: 41688931
Phenolic compounds that are produced by variety of industrial and urban activities pose dangers to live organisms and the…
Expand
2012
2012
Bernard Simeone. Traducteur de Luzi, Caproni et Sereni en France. Antonino Velez
Sophie Guermès
2012
Corpus ID: 193160858
Dans ce volume, Antonino Velez s’attache a retracer le travail de traducteur de Bernard Simeone, en choisissant de se focaliser…
Expand
2011
2011
Bidirectional transcription from human LRRTM2/CTNNA1 and LRRTM1/CTNNA2 gene loci leads to expression of N-terminally truncated CTNNA1 and CTNNA2 isoforms.
M. Kask
,
P. Pruunsild
,
T. Timmusk
Biochemical and Biophysical Research…
2011
Corpus ID: 27735799
2007
2007
Direct tissue MALDI-FTMS profiling of individual Cancer productus sinus glands reveals that one of three distinct combinations of crustacean hyperglycemic hormone precursor-related peptide (CPRP…
E. Stemmler
,
Yun-Wei A. Hsu
,
+4 authors
A. Christie
General and Comparative Endocrinology
2007
Corpus ID: 25207007
1986
1986
Morphologic and functional features of cyclic alternating pattern (CAP) sequences in normal NREM sleep.
M. Terzano
,
L. Parrino
,
G. Fioriti
,
M. C. Spaggiari
,
A. Piroli
Functional Neurology
1986
Corpus ID: 42918823
The Cyclic Alternating Pattern (CAP) is an EEG biphasic periodic activity of normal NREM sleep, generally organized in sequences…
Expand
1978
1978
Mutants of Acanthamoeba castellanii resistant to erythromycin, chloramphenicol, and oligomycin.
Jeffrey J. Seilhamer
,
Thomas J. Byers
The Journal of Protozoology
1978
Corpus ID: 38017392
Cell lines of Acanthamoeba castellanii resistant to erythromycin (EryR), chloramphenicol (CapR), and oligomycin (OliR) have been…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE